Viatris Agrees to Acquire Pacira BioSciences, Advancing Its Innovative Medicines Strategy and Becoming a Leader in Non-Opioid Pain Therapies

Impact · against what's priced in

PCRX is being acquired at a significant premium, providing immediate value realization for shareholders. VTRS gains high-margin, patent-protected assets and immediate EPS accretion with minimal impact on leverage, accelerating its transition toward innovative medicines.

PCRX+0.90: No priced-in read yet

Viatris Agrees to Acquire Pacira BioSciences, Advancing Its Innovative Medicines Strategy and Becoming a Leader in Non-Opioid Pain Therapies

What matters in this story

Futura Medical revises sale timetable as finance director steps down

Viatris Agrees to Acquire Pacira BioSciences, Advancing Its Innovative Medicines Strategy and Becoming a Leader in Non-Opioid Pain Therapies

What matters in this story

Futura Medical revises sale timetable as finance director steps down

How each ticker is affected

Connected tickers

Track these names every morning.

Axsome Therapeutics vs. Moderna: Which Biotech Stock Is a Better Buy in 2026?

Market Concentration Is Spooking Wall Street—I'm Buying Kenvue

Marvel Biosciences Reports MB-204 as Highly Effective at Treating Autism Behaviours in Shank3 Mouse Model

Movado Group, Inc. Enters Into Agreement to Sell Majority Interest in EBEL

Viatris Agrees to Acquire Pacira BioSciences, Advancing Its Innovative Medicines Strategy and Becoming a Leader in Non-Opioid Pain Therapies

What matters in this story

Next reads from the same story arc

Futura Medical revises sale timetable as finance director steps down

Viatris Agrees to Acquire Pacira BioSciences, Advancing Its Innovative Medicines Strategy and Becoming a Leader in Non-Opioid Pain Therapies

What matters in this story

Next reads from the same story arc

Futura Medical revises sale timetable as finance director steps down

How each ticker is affected

Connected tickers

Track these names every morning.

Axsome Therapeutics vs. Moderna: Which Biotech Stock Is a Better Buy in 2026?

Market Concentration Is Spooking Wall Street—I'm Buying Kenvue

Marvel Biosciences Reports MB-204 as Highly Effective at Treating Autism Behaviours in Shank3 Mouse Model

Movado Group, Inc. Enters Into Agreement to Sell Majority Interest in EBEL